Effects of Cefepime and Meropenem on the Gastrointestinal Colonization ofSurgical Patients by Candida albicans
Authors:
- N. ThomakosNTN. Thomakos
- T. LiakakosTLT. Liakakos
- A. MacherasAMA. Macheras
- D. MandrekasDMD. Mandrekas
- S. KanavakiSKS. Kanavaki
- D. BafaloukosDBD. Bafaloukos
- S. MarakiSMS. Maraki
- 17 September 2001
- journal article
- clinical trial
- Published by S. Karger AG in Chemotherapy
- Vol. 47 (5) , 350-353
Abstract
Background: The study evaluated the effects of cefepime and meropenem on the gastrointestinal (GI) colonization of surgical patients by Candida albicans. Patients and Methods: Twenty adult surgical patients who received intravenously either of these antibiotics as monotherapy for the treatment of an existing infection were studied prospectively. Ten patients received cefepime (2.0 g twice a day), and another ten meropenem (1.0 g every 8 h) for 7 days. Quantitative stool cultures for C. albicans were performed immediately before, at the end, and 1 week after the end of antibiotic treatment. Results: Both antibiotics increased the GI colonization of patients by Candida. Meropenem caused a higher increase (2.0 log10 CFU/g of stool) as compared to cefepime (1.7 log10 CFU/g of stool). However, these increases were statistically not significant. Conclusion: Cefepime and meropenem when given to sensitive patients do not increase significantly the risk of Candida infection originating in the GI tract.Keywords
This publication has 3 references indexed in Scilit:
- Effects of Cefepime, Cefixime and Ceftibuten on Murine Gut Colonization by Candida albicansChemotherapy, 1998
- Surgical Perspective on Invasive Candida InfectionsWorld Journal of Surgery, 1998
- The effect of antimicrobial agents on the ecology of the human intestinal microfloraVeterinary Microbiology, 1993